Navigation Links
Life on Mars 'pregnancy test' successfully launched

Washington DC*-- Key components of a new approach to discover life on Mars were successfully launched into space Friday as part of a twelve-day, low-Earth orbit experiment to assess their survivability in the space radiation environmenta prelude future journeys to Mars.

The new approach is based on technology similar to that used in pregnancy test kits. The so-called immunoassays are embodied in the Life Marker Chip (LMC) experiment, which has the potential to detect trace levels of biomarkers in the Martian environment. Biomarkers are molecular fingerprints that indicate if life currently is, or ever was, present on Mars. The LMC experiment has been proposed for the European Space Agencys ExoMars rover mission, which is planned for launch in 2013. The LMC experiment is in the development phase and is led by an international consortium with researchers including Andrew Steele, a staff member of Carnegies Geophysical Laboratory in the United States, and scientists from the United Kingdom, The Netherlands, and Germany.

For the current mission, the consortium developed a tiny component, measuring only 1.5 inches x 1.6 inches x .5 inch ( 3.8 cm x 4.1 cm x 1.3 cm) and housing over 2000 samples, to test that the key molecular components to be used in the LMC technology can survive the rigors of space.

The experiment was launched from Baikonur Cosmodrome in Kazakhstan as part of the European Space Agencys BIOPAN-6 experiment platform. The LMC components will experience both weightlessness and the harsh space radiation environment while orbiting the Earth 180 times at an altitude of up to 190 miles (308 km) during the 11.8 day mission.

The BIOPAN-6 platform is mounted on the outside of an un-manned Russian FOTON spacecraft. Once in space the BIOPAN-6 platform will open to expose its contents directly to the space environment, testing both their resistance to space radiation and the space vacuum, before closing and returning to Earth on September 25th. The LMC components will then be taken back to laboratories in the United Kingdom and the United States to analyze the effect of the space flight.

The lead members of the consortium involved in the current mission are Deutsches Zentrum fr Luft- und Raumfahrt (DLR) (Germany), Cranfield University (UK), Carnegie Institution of Washington (USA) and University of Leicester (UK).

Dr. Andrew Steele from the Carnegie Institution of Washington (USA) and one of the initial experiment proposers said, in the USA we are currently flying related technology and components within the protected environment of the International Space Station (ISS) but this will be the first time that these types of materials will have flown unprotected in space in a manner similar to a flight to Mars.

Dr. Lutz Richter of DLR (Germany) and the principal investigator for the current experiment said, This experiment is the culmination of a number of years of hard work and ground based tests to prove the viability of the LMC technology.

Dr. David Cullen, from Cranfield University (UK) and who leads the scientific input into the current experiment, said, ?this will be our first space experiment to demonstrate our belief that immunoassay technology will have an important future role in space exploration and the search for life elsewhere in the Solar System.

Dr. Mark Sims from the University of Leicester (UK) and who heads the overall LMC project said, this mission will be an important stepping stone in our ultimate goal of putting a LMC experiment on the surface of Mars and using it to search for evidence of Life.


Contact: Andrew Steele
Carnegie Institution

Related biology news :

1. Major new UNC-based drinking water study suggests pregnancy fears may be overstated
2. Any exposure to tobacco smoke during pregnancy is risky
3. Vitamin D deficiency widespread during pregnancy
4. Pregnancy drugs can affect grandkids
5. Major WHO study concludes calcium supplements can reduce complications during pregnancy
6. Study challenges myth that sex late in pregnancy hastens birth
7. Heavy smoking cuts womens chance of pregnancy -- even with donated oocytes
8. Pregnancy hormone key to repairing nerve cell damage
9. Experimental vaccine given during pregnancy reduces stillbirths from common virus
10. Procedure predicts embryos most likely to result in pregnancy
11. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
Post Your Comments:
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software company, ... Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , “I ... President and COO of STACS DNA. “In further expanding our capacity as a scientific ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology: